MXPA03011766A - Novedosos derivados de indol. - Google Patents

Novedosos derivados de indol.

Info

Publication number
MXPA03011766A
MXPA03011766A MXPA03011766A MXPA03011766A MXPA03011766A MX PA03011766 A MXPA03011766 A MX PA03011766A MX PA03011766 A MXPA03011766 A MX PA03011766A MX PA03011766 A MXPA03011766 A MX PA03011766A MX PA03011766 A MXPA03011766 A MX PA03011766A
Authority
MX
Mexico
Prior art keywords
indole derivatives
novel indole
disorders
disorder
psychosis
Prior art date
Application number
MXPA03011766A
Other languages
English (en)
Inventor
Andersen Kim
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of MXPA03011766A publication Critical patent/MXPA03011766A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Un derivado de heteroarilo que tiene la formula: (ver formula) en la cual A representa O u S; n es 2, 3, 4, 5, 6, 7, 8, 9 o 10; m es 2 o 3; W representa N, C o CH; Q representa N, C o CH; y la linea punteada representa un enlace opcional; R1 representa hidrogeno, alquilo de C1-6, alquenilo de C2-6, alquinilo de C2-6, cicloalquilo de C3-8-alquilo de C1-6, aril-alquilo de C1-6 o acilo; R2, R3, R4, R5 y R6 representan independientemente hidrogeno, halogeno, ciano, nitro, alquilo de C1-6, alcoxi de C1-6, alquilsulfailo de C1-6, alquilsulfonilo de C1-6, hidroxi, hidroxi-alquilo de C1-6, alcoxicarbonilo de C1-6, acilo, cicloalquilo de C3-8, cicloalquilo de C3-8 alquilo de C1-6, trifluorometilo, trifluorometoxi, NR15R16 en donde NR15R16 representan independientemente hidrogeno, alquilo de C1-6, cicloalquilo de C3-8 o fenilo; o R15 y R16 junto con el nitrogeno al cual estan unidos forman un anillo de 5 o 6 miembros que contiene optativamente un heteroatomo adicional; R7 y R7¦ representan independientemente hidrogeno o alquilo de C1-6 o pueden formar en conjunto un puente que consiste en dos o tres grupos metileno; R8, R9, R10 y R11 son cada uno independientemente seleccionados entre hidrogeno, halogeno, nitro, ciano, trifluorometilo, trifluorometoxi, alquilo de C1-6, alquenilo de C2-6, alquinilo de C2-6, cicloalquilo de C3-8, cicloalquilo de C3-8-alquilo de C1-6, fenilo, tiofenilo, alcoxi de C1-6, alquilsulfonilo de C1-6, alquilsulfonilo de C1-6, hidroxi, formilo, acilo, acilamino, aminocarbonilo, alcoxi de C1-6carbonilarnino, aminocarbonilamino, alquilo de C1-6aminocarbonilamino y di (alquilo de C1-6) aminocarbonilamino, NR13R14 en donde R13 y R14 representan independientemente hidrogeno, alquilo de C1-6, cicloalquilo de C3-8 o fenilo; o R13 y R14 junto con el nitrogeno al cual estan adheridos forman un anillo de 5 o 6 miembros que contiene optativamente un heteroatomo adicional; sus enantiomeros, y su sal de adicion de acido farmaceuticamente aceptable. Los compuestos de la invencion son considerados utiles para el tratamiento de trastornos afectivos tal como el trastorno de ansiedad general, trastorno de panico, trastorno obsesivo compulsivo, depresion, fobia social y trastornos de la alimentacion, y trastornos neurologicos tal como la sicosis.
MXPA03011766A 2001-06-29 2002-06-27 Novedosos derivados de indol. MXPA03011766A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101037 2001-06-29
PCT/DK2002/000436 WO2003002552A1 (en) 2001-06-29 2002-06-27 Novel indole derivatives

Publications (1)

Publication Number Publication Date
MXPA03011766A true MXPA03011766A (es) 2004-04-02

Family

ID=8160599

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03011766A MXPA03011766A (es) 2001-06-29 2002-06-27 Novedosos derivados de indol.

Country Status (28)

Country Link
US (1) US7342015B2 (es)
EP (1) EP1399434B1 (es)
JP (1) JP2004535448A (es)
KR (1) KR20040019027A (es)
CN (1) CN100338058C (es)
AR (1) AR034658A1 (es)
AT (1) ATE304007T1 (es)
AU (1) AU2002344950B2 (es)
BG (1) BG108538A (es)
BR (1) BR0210407A (es)
CA (1) CA2451229C (es)
CZ (1) CZ2004155A3 (es)
DE (1) DE60206043T2 (es)
DK (1) DK1399434T3 (es)
EA (1) EA006104B1 (es)
ES (1) ES2247347T3 (es)
HK (1) HK1069579A1 (es)
HU (1) HUP0400834A2 (es)
IL (1) IL158830A0 (es)
IS (1) IS2431B (es)
MX (1) MXPA03011766A (es)
NO (1) NO326513B1 (es)
NZ (1) NZ529461A (es)
PL (1) PL366520A1 (es)
SK (1) SK642004A3 (es)
UA (1) UA74651C2 (es)
WO (1) WO2003002552A1 (es)
ZA (1) ZA200308848B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK652004A3 (en) * 2001-06-29 2004-09-08 Lundbeck & Co As H Heteroaryl derivatives, pharmaceutical composition with the content thereof and use of the same
ATE443707T1 (de) 2004-11-26 2009-10-15 Janssen Pharmaceutica Nv Isoxazolin-indol-derivate mit verbesserter antipsychotischer und anxiolytischer aktivität
AR055203A1 (es) * 2005-08-31 2007-08-08 Otsuka Pharma Co Ltd Derivados de benzotiofeno con propiedades antipsicoticas
JP4785881B2 (ja) * 2007-02-27 2011-10-05 大塚製薬株式会社 医薬

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0900792B1 (en) 1997-09-02 2003-10-29 Duphar International Research B.V Piperazine and piperidine derivatives as 5-HT1A and dopamine D2-receptor (ant)agonists
CN1155567C (zh) * 1998-04-29 2004-06-30 惠氏公司 抑制精神的吲哚基衍生物
AR027134A1 (es) * 1999-12-30 2003-03-12 Lundbeck & Co As H Derivados de indol.
SK652004A3 (en) 2001-06-29 2004-09-08 Lundbeck & Co As H Heteroaryl derivatives, pharmaceutical composition with the content thereof and use of the same

Also Published As

Publication number Publication date
HUP0400834A2 (hu) 2004-08-30
US20060258678A1 (en) 2006-11-16
DE60206043D1 (de) 2005-10-13
SK642004A3 (en) 2004-05-04
NZ529461A (en) 2005-09-30
CA2451229A1 (en) 2003-01-09
JP2004535448A (ja) 2004-11-25
IL158830A0 (en) 2004-05-12
NO326513B1 (no) 2008-12-22
ATE304007T1 (de) 2005-09-15
NO20035672D0 (no) 2003-12-18
EP1399434A1 (en) 2004-03-24
EA200400104A1 (ru) 2004-04-29
CA2451229C (en) 2009-02-10
KR20040019027A (ko) 2004-03-04
DK1399434T3 (da) 2005-12-12
DE60206043T2 (de) 2006-06-29
CN1529703A (zh) 2004-09-15
ES2247347T3 (es) 2006-03-01
UA74651C2 (en) 2006-01-16
EA006104B1 (ru) 2005-08-25
WO2003002552A1 (en) 2003-01-09
HK1069579A1 (en) 2005-05-27
AU2002344950B2 (en) 2008-04-03
US7342015B2 (en) 2008-03-11
EP1399434B1 (en) 2005-09-07
IS7022A (is) 2003-11-10
BR0210407A (pt) 2004-08-17
NO20035672L (no) 2003-12-18
PL366520A1 (en) 2005-02-07
CZ2004155A3 (cs) 2004-07-14
BG108538A (bg) 2005-01-31
CN100338058C (zh) 2007-09-19
IS2431B (is) 2008-10-15
AR034658A1 (es) 2004-03-03
ZA200308848B (en) 2006-02-22

Similar Documents

Publication Publication Date Title
HK1068622A1 (en) Novel heteroaryl derivatives, their preparation and use
HUS2100028I1 (hu) ERBB I. típusú receptor tirozinkináz-gátló N4-fenil-kinazolin-4-amin származékok és rokon vegyületeik a hiperproliferatív betegségek kezelésére
RS20120158A3 (en) Phenyl-piperazine Derivatives As Serotonin Resorption Inhibitors
YU63202A (sh) Derivati 2-okso-1-pirolidina, postupci za njihovo dobijanje i njihove upotrebe
WO2002064594A3 (en) 6-substituted pyrido-pyrimidines
TW200510301A (en) Novel compounds
TW200407305A (en) Novel compounds
TW200510303A (en) Novel compounds
HRP20080262T3 (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
PT1626720E (pt) Derivados de 4-(2-fenilsulfanil-fenil)-piperidina como inibidores da recaptação da serotonina
ATE282605T1 (de) 2-thio-subsituierte imidazolderivative und ihre verwendung in der pharmazie
AU2002256334A1 (en) Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino(2,3-f)quinoxaline
MXPA03011766A (es) Novedosos derivados de indol.
EA200501579A1 (ru) Производные 4-(2-фенилсульфанилфенил)-1,2,3,6-тетрагидропиридина в качестве ингибиторов повторного поглощения серотонина
DE60204882D1 (de) Zykloalkenylsulfonamidderivate
UA81469C2 (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
UA85198C2 (ru) Производные морфолина как ингибиторы повторного поглощения норэпинефрина
UA81472C2 (en) 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors
CA2521030A1 (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors

Legal Events

Date Code Title Description
FG Grant or registration